ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2000–2020
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Atherosclerosis Supplements
Atherosclerosis Supplements is not currently indexed in Scopus. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ireland Ltd.
Checked against the index lists dated .
ISSN 1567-5688Verify ISSN ↗1878-5050Verify ISSN ↗
Publisher: Elsevier Ireland Ltd
Scopus · InactiveONOS
0
Indexed in
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Atherosclerosis Supplements indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2000–2020).
What is the impact factor of Atherosclerosis Supplements?
Atherosclerosis Supplements has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Atherosclerosis Supplements?
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Atherosclerosis Supplements and what is its ISSN?
Atherosclerosis Supplements is published by Elsevier Ireland Ltd. Its print ISSN is 1567-5688 and its online ISSN is 1878-5050.
Is Atherosclerosis Supplements covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Atherosclerosis Supplements in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Atherosclerosis Supplements open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Atherosclerosis Supplements for 21 years, between 2000 and 2020. Coverage ended in 2020, 6 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 13,639 works and 21,369 citations for the title. Its most recent paper is from 2020, in line with the end of Scopus coverage in 2020, which suggests the journal stopped publishing around then.
How well cited is Atherosclerosis Supplements? — open metrics via OpenAlex
Atherosclerosis Supplements has an h-index of 62 and a 2-year mean of 0 citations per paper (OpenAlex).
62
h-index
0
2-yr mean citations
341
i10-index
13,639
works indexed
21,369
total citations
Publication fee · open access list price, US$
US$3,000
Atherosclerosis Supplements published 21 papers in 2020; its busiest recent year was 2011 with 889. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Atherosclerosis Supplements? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2020. 2 retracted papers are recorded (0.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2020
- Retracted papers 2 · 0.1 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Elsevier Ireland Ltd
Elsevier Ireland Ltd has 54 other titles in our data; 49 are currently indexed in Scopus.
Related journals
8 journals Journal Indexed in
Atherosclerosis: X Not in these indexes Auris Nasus Larynx Scopus Q2 WoS SCIE Australian Critical Care Scopus Q1 WoS SCIE/SSCI BioSystems Scopus Q1 WoS SCIE Cancer Letters Scopus Q1 WoS SCIE Chemico-Biological Interactions Scopus Q1 WoS SCIE Chemistry and Physics of Lipids Scopus Q2 WoS SCIE Clinical and Translational Radiation Oncology Scopus Q1 WoS SCIE DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.